Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia

被引:8
作者
Daskalopoulou, Stella S.
Mikhailidis, Dimitri P.
机构
[1] Univ London, Sch Med, Royal Free & Univ Coll, London NW3 2QG, England
[2] McGill Univ, Royal Victoria Hosp, Dept Med, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada
关键词
combination therapy; ezetimibe; guidelines; liver function tests; low density lipoprotein cholesterol; rosuvastatin; simvastatin;
D O I
10.1185/030079906X148364
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent guidelines recommend strict goals for low density lipoprotein cholesterol ( LDL-C) ( 70 - 100 mg/dL; 1.8 - 2.6 mmol/L). These goals were set following the publication of several trials. In the current issue of the journal, a study compares different doses of the combination tablet ( ezetimibe/simvastatin) with statin monotherapy ( rosuvastatin). In keeping with previous literature, the combination therapy was more effective in achieving LDL-C goals. This editorial comments on the potential disadvantages of using monotherapy with high-dose statins and considers the issue of statin-induced proteinuria. Combination therapy may need to be increasingly used to achieve the LDL-C targets set by recent guidelines.
引用
收藏
页码:2037 / 2039
页数:3
相关论文
共 22 条
[1]   The safety of rosuvastatin as used in common clinical practice - A postmarketing analysis [J].
Alsheikh-Ali, AA ;
Ambrose, MS ;
Kuvin, JT ;
Karas, RH .
CIRCULATION, 2005, 111 (23) :3051-3057
[2]   The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study [J].
Athyros, VG ;
Mikhailidis, DP ;
Papageorgiou, AA ;
Symeonidis, AN ;
Pehlivanidis, AN ;
Bouloukos, VI ;
Elisaf, M .
JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (07) :728-734
[3]   Pathogenesis and treatment of kidney disease and hypertension - Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study [J].
Athyros, VG ;
Elisaf, M ;
Papageorgiou, AA ;
Symeonidis, AN ;
Pehlivanidis, AN ;
Bouloukos, VI ;
Milionis, HJ ;
Mikhailidis, DP .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) :589-599
[4]   Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease [J].
Barrios, V ;
Amabile, N ;
Paganelli, F ;
Chen, JW ;
Allen, C ;
Johnson-Levonas, AO ;
Massaad, R ;
Vandormael, K .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (12) :1377-1386
[5]   Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[6]   Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients [J].
Catapano, Alberico L. ;
Davidson, Michael H. ;
Ballantyne, Christie M. ;
Brady, William E. ;
Gazzara, Russell A. ;
Tomassini, Joanne E. ;
Tershakovec, Andrew M. .
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (10) :2041-2053
[7]  
Collins R, 2003, LANCET, V361, P2005
[8]   Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe [J].
Daskalopoulou, SS ;
Mikhailidis, DP .
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (03) :511-528
[9]   Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes - Phase Z of the A to Z trial [J].
de Lemos, JA ;
Blazing, MA ;
Wiviott, SD ;
Lewis, EF ;
Fox, KAA ;
White, HD ;
Rouleau, JL ;
Pedersen, TR ;
Gardner, LH ;
Mukherjee, R ;
Ramsey, KE ;
Palmisano, J ;
Bilheimer, DW ;
Pfeffer, MA ;
Califf, RM ;
Braunwald, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (11) :1307-1316
[10]   The DISCOVERY PENTA study:: a DIrect Statin COmparison of LDL-C value -: an Evaluation of Rosuvastatin therapY compared with atorvastatin [J].
Fonseca, FAH ;
Ruiz, A ;
Cardona-Muñoz, EG ;
Silva, JM ;
Fuenmayor, N ;
Marotti, M .
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) :1307-1315